...
mira-img

MIRA Pharmaceuticals, Inc. Common Stock, Common Stock

MIRA

NAQ

$1.12

+$0

(0%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$19.05M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
262.98K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.51 L
$5.01 H
$1.12

About MIRA Pharmaceuticals, Inc. Common Stock, Common Stock

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameMIRASectorS&P500
1-Week Return-5.88%-2.27%-0.57%
1-Month Return-28.21%-3.96%1.21%
3-Month Return-17.04%-9.7%7.57%
6-Month Return57.72%-3.37%11.45%
1-Year Return-18.84%3.71%28.48%
3-Year Return-84.91%3.8%29.52%

Financials

Dec '20Dec '21Dec '22Dec '23
Total Revenue----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue---8.53M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit---(8.53M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-852604900,"profit":false}]
Gross Margin----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses67.63K2.15M7.05M8.53M[{"date":"2020-12-31","value":0.79,"profit":true},{"date":"2021-12-31","value":25.24,"profit":true},{"date":"2022-12-31","value":82.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(67.63K)(2.15M)(7.05M)(8.53M)[{"date":"2020-12-31","value":-6763000,"profit":false},{"date":"2021-12-31","value":-215216200,"profit":false},{"date":"2022-12-31","value":-704794000,"profit":false},{"date":"2023-12-31","value":-852605000,"profit":false}]
Total Non-Operating Income/Expense-(48.75K)(20.50K)(4.18M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-4874800,"profit":false},{"date":"2022-12-31","value":-2050000,"profit":false},{"date":"2023-12-31","value":-418333200,"profit":false}]
Pre-Tax Income(67.99K)(2.18M)(7.06M)(11.98M)[{"date":"2020-12-31","value":-6799300,"profit":false},{"date":"2021-12-31","value":-217653600,"profit":false},{"date":"2022-12-31","value":-705819000,"profit":false},{"date":"2023-12-31","value":-1198234300,"profit":false}]
Income Taxes(202.89)(2.15K)(7.05K)(8.53K)[{"date":"2020-12-31","value":-20289,"profit":false},{"date":"2021-12-31","value":-215216,"profit":false},{"date":"2022-12-31","value":-704794,"profit":false},{"date":"2023-12-31","value":-852605,"profit":false}]
Income After Taxes-(2.17M)(7.05M)(11.97M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-217438384,"profit":false},{"date":"2022-12-31","value":-705114206,"profit":false},{"date":"2023-12-31","value":-1197381695,"profit":false}]
Income From Continuous Operations-(2.18M)(7.06M)(7.54M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-217653600,"profit":false},{"date":"2022-12-31","value":-705819000,"profit":false},{"date":"2023-12-31","value":-754444400,"profit":false}]
Income From Discontinued Operations----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(67.99K)(2.18M)(7.06M)(11.98M)[{"date":"2020-12-31","value":-6799300,"profit":false},{"date":"2021-12-31","value":-217653600,"profit":false},{"date":"2022-12-31","value":-705819000,"profit":false},{"date":"2023-12-31","value":-1198234300,"profit":false}]
EPS (Diluted)---(0.75)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-75.15,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MIRA
Cash Ratio 5.98
Current Ratio 6.11

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MIRA
ROA (LTM) -177.53%
ROE (LTM) -748.59%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MIRA
Debt Ratio Lower is generally better. Negative is bad. 0.16
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.84

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MIRA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 5.19
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is MIRA Pharmaceuticals, Inc. Common Stock share price today?

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) share price today is $1.12

Can Indians buy MIRA Pharmaceuticals, Inc. Common Stock shares?

Yes, Indians can buy shares of MIRA Pharmaceuticals, Inc. Common Stock (MIRA) on Vested. To buy MIRA Pharmaceuticals, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MIRA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of MIRA Pharmaceuticals, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of MIRA Pharmaceuticals, Inc. Common Stock (MIRA) via the Vested app. You can start investing in MIRA Pharmaceuticals, Inc. Common Stock (MIRA) with a minimum investment of $1.

How to invest in MIRA Pharmaceuticals, Inc. Common Stock shares from India?

You can invest in shares of MIRA Pharmaceuticals, Inc. Common Stock (MIRA) via Vested in three simple steps:

  • Click on Sign Up or Invest in MIRA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in MIRA Pharmaceuticals, Inc. Common Stock shares
What is MIRA Pharmaceuticals, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is $5.01. The 52-week low price of MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is $0.51.

What is MIRA Pharmaceuticals, Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is

What is MIRA Pharmaceuticals, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is 5.19

What is MIRA Pharmaceuticals, Inc. Common Stock dividend yield?

The dividend yield of MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is 0.00%

What is the Market Cap of MIRA Pharmaceuticals, Inc. Common Stock?

The market capitalization of MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is $19.05M

What is MIRA Pharmaceuticals, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of MIRA Pharmaceuticals, Inc. Common Stock is MIRA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top